MARKET

IVVD

IVVD

Invivyd
NASDAQ
1.470
-0.020
-1.34%
After Hours: 1.480 +0.01 +0.68% 19:44 05/13 EDT
OPEN
1.490
PREV CLOSE
1.490
HIGH
1.490
LOW
1.420
VOLUME
1.96M
TURNOVER
--
52 WEEK HIGH
3.070
52 WEEK LOW
0.4830
MARKET CAP
415.72M
P/E (TTM)
-4.8228
1D
5D
1M
3M
1Y
5Y
1D
Here are the major earnings before the open Thursday
Seeking Alpha · 8h ago
Invivyd's First Quarter May Show Whether Pemgarda Revenue Can Sustain Momentum—If It Shows Up
Barchart · 14h ago
Invivyd Q1 2026 Earnings Preview
Seeking Alpha · 15h ago
Upstream Bio, Inc. (UPB) Reports Q1 Loss, Beats Revenue Estimates
NASDAQ · 18h ago
Invivyd EVADE Trial Data Reveals Monoclonal Antibody VYD2311 Demonstrates Minimal Tolerability Issues Versus COVID mRNA Vaccination
Benzinga · 2d ago
Invivyd plans LIBERTY trial comparing VYD2311 tolerability with mRNA COVID vaccine
PUBT · 2d ago
INVIVYD AND COLLABORATORS AUTHOR NEW MANUSCRIPT EVALUATING EARLY TOLERABILITY OF COVID MONOCLONAL ANTIBODY AND COMPARING RESULTS TO COVID VACCINATION
Reuters · 2d ago
Weekly Report: what happened at IVVD last week (0504-0508)?
Weekly Report · 2d ago
More
About IVVD
Invivyd, Inc. is a biopharmaceutical company. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The Company delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2. Its PEMGARDA (pemivibart) is the Company's first mAb to receive regulatory authorization and is designed to keep pace with SARS-CoV-2 viral evolution. PEMGARDA is used for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents. Its VYD2311 is optimized for neutralization potency against SARS-CoV-2 lineages such as BA.2.86 and JN.1. The Company also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.

Webull offers Invivyd Inc stock information, including NASDAQ: IVVD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVVD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVVD stock methods without spending real money on the virtual paper trading platform.